Maurice Wilson
Corneal and Contact Management · Conroe, TXNPI 1881601565
Payments from drug & device makers
Across 703 payments — averaging $514.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$360K
- AbbVie$634
- Glaukos Corporation$467
- Bausch & Lomb Americas Inc.$283
- Regeneron Healthcare Solutions, Inc.$134
- Bausch & Lomb, A Division Of Bausch Health US, LLC$125
What the payments were for
- Consulting fees$192,05853%
- Speaking & faculty fees$75,66121%
- Travel & lodging$77,25921%
- Food & beverage$16,7575%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 688 | $360,091 |
| AbbVie(2 entities) | 8 | $634 |
| Glaukos Corporation | 3 | $467 |
| Bausch & Lomb Americas Inc. | 2 | $283 |
| Regeneron Healthcare Solutions, Inc. | 1 | $134 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOTAL30$133,804
- DAILIES TOTAL1$112,393
- DAILIES$87,704
- Precision 1$85,100
- Precision7$26,513
- AIR OPTIX$25,498
- ILUX$15,390
- Dailies Aqua Comfort Plus$8,731
- DAILIES TOTAL1 Multifocal$7,985
- Air Optix plus HydraGlyde$1,500
- DAILIES Multifocal$795
- Systane$265
- INFUSE$250
- VUITY$216
- Photrexa Viscous and Photrexa$195
- EYLEA$134
- Clareon$127
- DURYSTA$125
- CE-marked KXLA system$109
How this compares
$361,734 in reported general payments places this provider in the 95th percentile of 103 corneal and contact management providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 19 | $139 |
| Latanoprost | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Conroe
- Roberto SaenzSan Antonio$861K
- Fariba ParmerGrapevine$26K
- Vissett SunHouston$13K
- Napoleon LoveroHouston$12K
- Sairah MalikHouston$10K
- Darlene JonesPlano$9K
- Heriberto RamosCorpus Christi$9K
- Glenn EllisorKingwood$7K
- Danny MalonePlano$7K
- Leigh GreenWaco$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.